Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01805180 · ClinicalTrials.gov registry record · NA
Evaluation of the Spectra Optia PMN Cell Collection Procedure
A NA study, sponsored by Terumo BCT.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01805180 is a NA study that has completed, run by Terumo BCT. The registered enrollment target is 42 participants.
The verdict
NCT01805180, a NA study, has completed, sponsored by Terumo BCT.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the procedures for the collection PMN cells on Terumo BCT's Spectra Optia® and COBE® Spectra Apheresis Systems.
Interventions
- DEVICE Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System)
- DEVICE Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01805180
The ClinicalTrials.gov registry entry for NCT01805180 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terumo BCT, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System) is the first listed.
NCT01805180 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01805180 about?
NCT01805180 is a clinical study titled "Evaluation of the Spectra Optia PMN Cell Collection Procedure". The purpose of this study is to compare the procedures for the collection PMN cells on Terumo BCT's Spectra Optia® and COBE® Spectra Apheresis Systems.
What is the current status of trial NCT01805180?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2013-02. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01805180?
The interventions under investigation include: Granulocyte/Polymorphonuclear Cell Collection (COBE Spectra System) (DEVICE), Granulocyte/Polymorphonuclear Cell Collection (Spectra Optia System) (DEVICE).
Who is sponsoring clinical trial NCT01805180?
This trial is sponsored by Terumo BCT, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.